文献速递神经核医学

早期β-淀粉样蛋白正电子发射断层显像与阿尔茨海默病患者神经心理测试的相关性

Correlation of early-phase β-amyloid positron-emission-tomography and neuropsychological testing in patients with Alzheimer's disease.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-02-28

该研究纳入82例经ATN分类生物学定义阿尔茨海默病患者,评估早期β-淀粉样蛋白PET区域灌注缺损与神经心理测试的关联,并按Braak分期分组。结果显示较低认知表现与早期PET全局及区域灌注减低相关,以左颞叶最明显;颞叶和顶叶区域平均z评分可稳健预测23例随访患者未来MMSE和CERAD-Plus总分年下降。

要点

  • stage0和stageI-II+组神经心理表现显著优于stageI-IV+和stageI-VI+组。
  • 认知表现较低与早期β-淀粉样蛋白PET全局及区域灌注减低相关,左颞叶最明显。
  • 颞叶和顶叶区域平均z评分可稳健预测未来MMSE和CERAD-Plus总分年下降。

核心结论

  • 早期β-淀粉样蛋白PET的区域和全局灌注缺损可作为神经退行性病变严重程度的客观指标,并可能作为AD未来认知下降的预后标志物。

研究设计与样本

  • 研究纳入82例经ATN分类生物学定义的阿尔茨海默病患者,评估早期β-淀粉样蛋白PET区域灌注缺损及神经心理测试(最长延迟90天)。
  • 参照Braak分期系统,根据阿尔茨海默病神经影像学倡议(ADNI)公布感兴趣区(ROIs)的区域灌注缺损,将患者分为stage0、stageI-II+、stageI-IV+、stageI-VI+和stageatypical+组。
  • 采用控制年龄、性别和教育的多元回归分析,评估灌注相PET区域z评分与全部患者临床评分及23例有随访数据患者认知表现年下降的关联。

主要发现

  • stage0和stageI-II+组患者神经心理表现显著优于stageI-IV+和stageI-VI+组患者。
  • 较低认知表现与早期β-淀粉样蛋白PET全局和区域灌注减低相关,以左颞叶关联最明显。
  • 颞叶和顶叶区域早期PET平均z评分可稳健预测未来MMSE和CERAD-Plus(阿尔茨海默病注册联盟)测试组合总分的年下降。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Clinical staging in individuals with Alzheimer's disease (AD) typically relies on neuropsychological testing. Recognizing the imperative for an objective measure of clinical AD staging, regional perfusion in early-phase β-amyloid-PET may aid as a cost-efficient index for the assessment of neurodegeneration severity in patients with Alzheimer's disease. METHODS: Regional perfusion deficits in early-phase β-amyloid-PET as well as neuropsychological testing (max. 90 days delay) were evaluated in 82 patients with biologically defined AD according to the ATN classification. In reference to the Braak staging system patients were classified into the groups stage0, stageI-II+, stageI-IV+, stageI-VI+, and stageatypical+ according to regional perfusion deficits in regions of interest (ROIs) published by the Alzheimer's Disease Neuroimaging Initiative. Multiple regression analysis controlling for age, gender, and education was used to evaluate the association of regional z-scores on perfusion-phase PET with clinical scores for all patients and with annual decline of cognitive performance in 23 patients with follow-up data. RESULTS: Patients classified as stage0 and stageI-II+ demonstrated significantly superior neuropsychological performance compared to those classified as stageI-IV+ and stageI-VI+. Lower cognitive performance was associated with decreased perfusion in early-phase β-amyloid-PET globally and regionally, with the most pronounced association identified in the left temporal lobe. Mean z-scores on early-phase PET in temporal and parietal regions offered a robust prediction of future annual decline in MMSE and sum scores of the CERAD-Plus (Consortium to Establish a Registry for Alzheimer's Disease) test battery. CONCLUSION: Regional and global perfusion deficits in early-phase β-amyloid-PET can serve as an objective index of neurodegeneration severity and may act as prognostic markers of future cognitive decline in AD.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Völter F, Eckenweber S, Scheifele M, et al. Correlation of early-phase β-amyloid positron-emission-tomography and neuropsychological testing in patients with Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2025. PMID: 40019578. doi:10.1007/s00259-025-07175-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。